Search - tctmd.com

Displaying 101 - 120 of 238

Sort: Relevancy | Date

News Conference News TCT 2014

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

September 16, 2014

News Industry News

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

September 16, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation

September 16, 2014

Presentation TCT 2014

Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension: Vascular Dynamics

Presenter: Daniel Burkhoff, Felix Mahfoud, Jose Luis Assad-Morell, Sahil A. Parikh, Mark C. Bates

September 15, 2014

Presentation TCT 2014

A Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension (Vascular Dynamics)

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Mark C. Bates

September 14, 2014

Presentation TCT 2014

Resistant Hypertension!

Presenter: Atul Pathak

September 14, 2014

Presentation TCT 2014

Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Thomas F. Luscher

September 13, 2014

Presentation TCT 2014

Current Status of Advanced Hypertension Treatment in the United States

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Michael A. Weber

September 13, 2014

Presentation TCT 2014

What it Means to Have (and Be) a Hypertension Referral Center

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, C. Venkata S. Ram

September 13, 2014

Presentation TCT 2014

Workup and Treatment of Hypertension: From A to Z

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Atul Pathak

September 13, 2014

News Industry News

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

September 13, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Industry News

Kona Medical Initiates Clinical Trial of Non-Invasive Therapy for Resistant Hypertension

August 27, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Daily News

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

Yael L. Maxwell

June 11, 2014

News Daily News

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

Yael L. Maxwell

June 11, 2014

Presentation

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Presenter: Murray D. Esler

June 10, 2014

Advertisement

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

Experts Debate Future of Renal Denervation

Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension: Vascular Dynamics

A Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension (Vascular Dynamics)

Resistant Hypertension!

Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World

Current Status of Advanced Hypertension Treatment in the United States

What it Means to Have (and Be) a Hypertension Referral Center

Workup and Treatment of Hypertension: From A to Z

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Experts Debate Future of Renal Denervation Therapy

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Kona Medical Initiates Clinical Trial of Non-Invasive Therapy for Resistant Hypertension

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content